Kenny S. Frazier
Plus aucun poste en cours
Profil
Kenny S.
Frazier held the position of Senior Director-Clinical Operations at Lexicon Pharmaceuticals, Inc. and the position of VP-Clinical Development & Regulatory Affairs at Opexa Therapeutics, Inc. He obtained an undergraduate degree from Texas Tech University.
Anciens postes connus de Kenny S. Frazier
| Sociétés | Poste | Fin |
|---|---|---|
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Directeur Technique/Scientifique/R&D | - |
| LEXICON PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 13/09/2012 |
Formation de Kenny S. Frazier
| Texas Tech University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | Health Technology |
